-
One of the nations leading medical messaging services has taken the lead in developing a sound business associate agreement to present to its clients to fulfill HIPAA requirements.
-
The Workgroup for Electronic Data Interchange (WEDI) has asked Health and Human Services Secretary Tommy Thompson to provide guidance in light of the fact that a substantial number of covered entities will not be able to achieve compliance with HIPAA Transaction and Code Set (TCS) standards by Oct. 16, 2003, as required under the Administrative Simplification Compliance Act.
-
As with many areas of health care, new approaches in technology have been sought to ease the way into compliance with HIPAA. One example is the HIPAA GUARD program from Monterey, CA-based Integritas Inc.
-
A Strategy to Reduce Cardiovascular Disease by More Than 80 Percent; Pearly Penile Papules: Still No Reason for Uneasiness; The Epidemiology of Major Depressive Disorder
-
Only about 12% of patients with new onset atrial fibrillation who did not have apparent contraindications to warfarin treatment filled prescriptions for it.
-
Peripheral arterial disease is common. Screening with measurement of the ankle-brachial index will improve detection.
-
The low-carbohydrate diet produced a greater weight loss than did the conventional diet for the first 6 months, but the differences were not significant at 1 year.
-
The association of caffeine and nicotine in pharmaceutical products and aneurysmal SAH warrants further study.
-
Women who survive breast cancer may be at a lower risk of developing coronary artery disease compared with women without a history of breast cancer.
-
The FDA has approved the first once-daily protease inhibitor (PI) for the treatment of HIV-1 infections. Atazanavir (Bristol-Myers Squibb) is the newest PI to enter this relatively crowded class. It is marketed under the trade name Reyataz.
